1114 related articles for article (PubMed ID: 7768881)
1. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
Lehmann JM; Moore LB; Smith-Oliver TA; Wilkison WO; Willson TM; Kliewer SA
J Biol Chem; 1995 Jun; 270(22):12953-6. PubMed ID: 7768881
[TBL] [Abstract][Full Text] [Related]
2. Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro.
Su JL; Winegar DA; Wisely GB; Sigel CS; Hull-Ryde EA
Hybridoma; 1999 Jun; 18(3):273-80. PubMed ID: 10475242
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen CB; Lazar MA
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5793-6. PubMed ID: 8650171
[TBL] [Abstract][Full Text] [Related]
4. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman BM
Diabetes; 1998 Apr; 47(4):507-14. PubMed ID: 9568680
[TBL] [Abstract][Full Text] [Related]
5. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
Forman BM; Tontonoz P; Chen J; Brun RP; Spiegelman BM; Evans RM
Cell; 1995 Dec; 83(5):803-12. PubMed ID: 8521497
[TBL] [Abstract][Full Text] [Related]
7. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
Kliewer SA; Lenhard JM; Willson TM; Patel I; Morris DC; Lehmann JM
Cell; 1995 Dec; 83(5):813-9. PubMed ID: 8521498
[TBL] [Abstract][Full Text] [Related]
8. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.
Vázquez M; Silvestre JS; Prous JR
Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):515-23. PubMed ID: 12500431
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte differentiation is regulated by a prostaglandin liganded to the nuclear peroxisome proliferator-activated receptor.
Wolf G
Nutr Rev; 1996 Sep; 54(9):290-2. PubMed ID: 9009672
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
Gimble JM; Robinson CE; Wu X; Kelly KA; Rodriguez BR; Kliewer SA; Lehmann JM; Morris DC
Mol Pharmacol; 1996 Nov; 50(5):1087-94. PubMed ID: 8913339
[TBL] [Abstract][Full Text] [Related]
11. Interdomain communication regulating ligand binding by PPAR-gamma.
Shao D; Rangwala SM; Bailey ST; Krakow SL; Reginato MJ; Lazar MA
Nature; 1998 Nov; 396(6709):377-80. PubMed ID: 9845075
[TBL] [Abstract][Full Text] [Related]
12. Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells.
Hida Y; Kawada T; Kayahashi S; Ishihara T; Fushiki T
Life Sci; 1998; 62(14):PL205-11. PubMed ID: 9570344
[TBL] [Abstract][Full Text] [Related]
13. [Adipocyte differentiation and nuclear receptor].
Hirose T; Kurebayashi S
Nihon Rinsho; 1997 Jun; 55(6):1596-604. PubMed ID: 9200953
[TBL] [Abstract][Full Text] [Related]
14. PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic.
Misra P; Chakrabarti R; Vikramadithyan RK; Bolusu G; Juluri S; Hiriyan J; Gershome C; Rajjak A; Kashireddy P; Yu S; Surapureddi S; Qi C; Zhu YJ; Rao MS; Reddy JK; Ramanujam R
J Pharmacol Exp Ther; 2003 Aug; 306(2):763-71. PubMed ID: 12730351
[TBL] [Abstract][Full Text] [Related]
15. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
[TBL] [Abstract][Full Text] [Related]
16. The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP.
Mizukami J; Taniguchi T
Biochem Biophys Res Commun; 1997 Nov; 240(1):61-4. PubMed ID: 9367882
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.
Wang C; Pattabiraman N; Zhou JN; Fu M; Sakamaki T; Albanese C; Li Z; Wu K; Hulit J; Neumeister P; Novikoff PM; Brownlee M; Scherer PE; Jones JG; Whitney KD; Donehower LA; Harris EL; Rohan T; Johns DC; Pestell RG
Mol Cell Biol; 2003 Sep; 23(17):6159-73. PubMed ID: 12917338
[TBL] [Abstract][Full Text] [Related]
18. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
19. Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation.
Tai TA; Jennermann C; Brown KK; Oliver BB; MacGinnitie MA; Wilkison WO; Brown HR; Lehmann JM; Kliewer SA; Morris DC; Graves RA
J Biol Chem; 1996 Nov; 271(47):29909-14. PubMed ID: 8939934
[TBL] [Abstract][Full Text] [Related]
20. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
Adams M; Montague CT; Prins JB; Holder JC; Smith SA; Sanders L; Digby JE; Sewter CP; Lazar MA; Chatterjee VK; O'Rahilly S
J Clin Invest; 1997 Dec; 100(12):3149-53. PubMed ID: 9399962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
